T0	Participants 40 82	patients with fibrocystic breast disease].
T1	Participants 156 193	patients with fibrocystic mastopathy.
T2	Participants 215 282	Patients with diagnosis of fibrocystic breast disease were included
T3	Participants 749 812	39 patients with alpha dihidroergocriptine and 38 with placebo.
T4	Participants 1665 1692	fribrocystic breast disease